Maternal Docosahexaenoic Acid Supplementation and Infant Neurodevelopmental Outcomes at Twelve Months: A Randomized, Placebo-Controlled Trial. JCNFS. 2025;8(1):9-16. doi:10.5281/zenodo.22343522